Institutional Ownership
Nuo Therapeutics Inc
CUSIP 67059V209COMAURXQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
39.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Jacobs Paul Anthony | 13G/A | 6.6% | 318.35B | SEC |
| 2 | Jan 26, 2026 | Pittman Scott M. | 13D/A | 11.6% | — | SEC |
| 3 | Nov 14, 2024 | Flynn James E | 13G/A | 2.2% | 1.03M | SEC |
| 4 | Oct 22, 2024 | Jacobs Paul Anthony | 13G/A | 6.0% | 2.80M | SEC |
| 5 | Feb 14, 2024 | Jacobs Paul Anthony | 13G | 5.7% | 2.50M | SEC |
| 6 | Feb 12, 2024 | Flynn James E | 13G/A | 5.2% | 2.18M | SEC |
| 7 | Dec 20, 2023 | Pittman Scott M. | 13D/A | 12.1% | 5.40M | SEC |
| 8 | Jul 5, 2022 | Sheedy Charles E | 13D/A | 39.0% | 13.10M | SEC |
| 9 | Jul 5, 2022 | Pittman Scott M. | 13D/A | 18.6% | 5.92M | SEC |
| 10 | Jul 5, 2022 | Jorden David Emerson | 13D | 8.9% | 2.77M | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Nuo Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ancora Advisors LLC | 4.7K | $6.8K |